Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Non-Current ReceivablesReceivables - NetReceivables - OtherReceivables Refunds
Ratios

Sanofi (SNY) Receivables - Other (2016 - 2025)

Sanofi's Receivables - Other history spans 11 years, with the latest figure at $1.7 billion for Q4 2025.

  • For Q4 2025, Receivables - Other rose 11.49% year-over-year to $1.7 billion; the TTM value through Dec 2025 reached $1.7 billion, up 11.49%, while the annual FY2025 figure was $1.7 billion, 6.84% up from the prior year.
  • Receivables - Other for Q4 2025 was $1.7 billion at Sanofi, up from $1.5 billion in the prior quarter.
  • Across five years, Receivables - Other topped out at $1.7 billion in Q4 2025 and bottomed at $920.9 million in Q4 2021.
  • The 5-year median for Receivables - Other is $1.5 billion (2024), against an average of $1.4 billion.
  • The largest annual shift saw Receivables - Other skyrocketed 42.81% in 2022 before it decreased 0.82% in 2024.
  • A 5-year view of Receivables - Other shows it stood at $920.9 million in 2021, then surged by 42.81% to $1.3 billion in 2022, then grew by 18.47% to $1.6 billion in 2023, then decreased by 0.82% to $1.5 billion in 2024, then grew by 11.49% to $1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for SNY's Receivables - Other are $1.7 billion (Q4 2025), $1.5 billion (Q4 2024), and $1.6 billion (Q4 2023).